$AARD

$0.98 -$0.41 (29.85%) Live

$AARD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$AARD Management Team

Dr. Tien-Li Lee

Chief Executive Officer

Founder

Director

Age 50

Compensation $906.3K USD

Sex Male

Mr. Timothy Kieffer

Chief Scientific Officer

Age -

Compensation -

Sex Male

Dr. Manasi Jaiman

Chief Medical Officer

Age 44

Compensation $812.5K USD

Sex Female

Mr. Danny Villeneuve

Chief Commercial Officer

Age -

Compensation -

Sex Male

Mr. Nelson Sun

Chief Financial Officer

Chief Operating Officer

Age 48

Compensation -

Sex Male

Mr. Derrick Li

Chief Business Officer

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Tien-Li Lee Chief Executive Officer Founder Director	50	$906.3K USD	Male
Mr. Timothy Kieffer Chief Scientific Officer	-	-	Male
Dr. Manasi Jaiman Chief Medical Officer	44	$812.5K USD	Female
Mr. Danny Villeneuve Chief Commercial Officer	-	-	Male
Mr. Nelson Sun Chief Financial Officer Chief Operating Officer	48	-	Male
Mr. Derrick Li Chief Business Officer	-	-	Male

Board of Directors

From the proxy statement filed Jul 10, 2026

Directors

serving now

Independent

4 of 5

stated in the proxy

Average tenure

4.4 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Tien-Li Lee, M.D. CEO	51	2017 9 years	Not independent	None stated	None stated	Paid as CEO
Jeffrey Chi, Ph.D. Lead independent director	58	2019 7 years	Independent	Audit Committee Nominating and Corporate Governance Committee	Jing-jin Electric Technologies Co., Ltd. (SH: 668280)	$608,870
Victor Tong, Jr.	42	2024 2 years	Independent	Audit Committee	CG Oncology, Inc. (Nasdaq: CGON)	$588,873
Susan E. Graf	53	2024 2 years	Independent	Compensation Committee	CG Oncology, Inc. (Nasdaq: CGON)	$339,130
Roy D. Baynes, M.D., Ph.D.	71	2024 2 years	Independent	Compensation Committee Nominating and Corporate Governance Committee	Natera, Inc. (Nasdaq: NTRA), Travere Therapeutics Inc. (formerly known as Retrophin, Inc.) (Nasdaq: TVTX), Nurix Therapeutics, Inc. (Nasdaq: NRIX)	$325,942

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Jul 10, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$AARD Management Team

Dr. Tien-Li Lee

Mr. Timothy Kieffer

Dr. Manasi Jaiman

Mr. Danny Villeneuve

Mr. Nelson Sun

Mr. Derrick Li

Board of Directors

Related-party transactions

No related-party transactions disclosed